Palo Verde Hematology Oncology, LTD
Updated Filing received by DOL
Palo Verde Hematology Oncology, LTD, a healthcare & social assistance employer in Glendale, Arizona, reported 291 participants in its health and welfare plan for plan year 2025. Its Form 5500 shows 4 insurance contracts with no premium reported and $147,253 in broker commissions and fees. The plan is a mix of insured and self-funded coverage. The Department of Labor received the filing on September 3, 2026, within the extension window.
Who was paid on Palo Verde Hematology Oncology, LTD's plan
Schedule A, Part I lists each broker or agent paid on each insurance contract and the amount. Totals below add every contract Palo Verde Hematology Oncology, LTD filed for 2025.
| Broker or agent | Commissions | Fees | Total | Contracts |
|---|---|---|---|---|
| Marsh McLennan Agency · King of Prussia, PA | $131,613 | $3,087 | $134,700 | 4 |
| Gibson Insurance Agency, Inc. · South Bend, IN | $12,553 | $0 | $12,553 | 2 |
Source: DOL Form 5500 Schedule A, Part I (broker commissions and fees), plan year 2025, as published in EBSA's 2025 "Latest" dataset. Part I names whoever the carrier paid, which can be a firm or an individual agent; both are public record. Amounts exclude pay from carriers not tied to a listed contract.
Insurance contracts and carriers
Every insurance contract reported on Schedule A: carrier, what it covers, people covered at year end, earned premium, and broker compensation.
| Carrier · coverage | Covered | Premium | Broker pay | Rate |
|---|---|---|---|---|
| Blue Cross Blue Shield of Arizonahealth, prescription drug | 148 | — | $102,325 | — |
| Metropolitan Life Insurance Companyvision | 176 | — | $2,009 | — |
| Solstice Benefits, Incdental | 180 | — | $10,586 | — |
| Reliance Standard Life Insurance Companylife, short-term disability, long-term disability | 291 | — | $32,333 | — |
Source: DOL Form 5500 Schedule A, plan year 2025. Self-funded medical coverage has no premium; amounts shown for it are stop-loss or administrative contracts.
How Palo Verde Hematology Oncology, LTD compares
Medians across employers for plan year 2024, the most recent complete year. Commission rates use fully insured medical contracts only; dollar medians use every employer that disclosed broker pay.
Not computable: no insured medical premium on the filing.
Source: BenefitsLedger benchmarks from 58,547 employer health plans with 100 or more participants, plan year 2024. Methodology.
Year over year
| 2024 | 2025 | Change | |
|---|---|---|---|
| Participants | 271 | 291 | +7.4% |
| Premiums filed | $0 | $0 | not comparable |
| Broker commissions + fees | $169,225 | $147,253 | −13.0% |
| Commission rate | — | — | — |
Source: DOL Form 5500 filings for plan years 2024 and 2025.
Filings and timeliness
Plans this employer filed under its EIN with a health benefit code. Large plans are due seven months after the plan year ends, or two and a half months later with an extension; amended filings carry the amendment date, so no timing is asserted for them.
| Plan | Plan year end | Received by DOL | Timing | Participants |
|---|---|---|---|---|
| Palo Verde Hematology Oncology, LTD Health and Welfare Plan#501 · insurance, general assets | December 31, 2025 | September 3, 2026 | within extension | 291 |
Source: DOL Form 5500 Part I and signature dates; "late" means received after the extended deadline (the 15th day of the tenth month after plan year end). What a late Form 5500 costs.
How much did Palo Verde Hematology Oncology, LTD pay in health insurance broker commissions in 2025?
Palo Verde Hematology Oncology, LTD's 2025 Form 5500 reports $147,253 in broker commissions and fees across 4 insurance contracts ($144,166 in commissions, $3,087 in fees), with Marsh McLennan Agency receiving the largest share.
Is Palo Verde Hematology Oncology, LTD's health plan self-funded or fully insured?
The 2025 filing indicates the plan is a mix of insured and self-funded coverage. Medical coverage is written by Blue Cross Blue Shield of Arizona.
How does Palo Verde Hematology Oncology, LTD's broker compensation compare with similar employers?
A commission-to-premium ratio cannot be computed for Palo Verde Hematology Oncology, LTD because the filing does not report medical premium on Schedule A (usual for self-funded plans). In dollars, employers with 200-499 participants that disclosed broker pay reported a median of $77,013.
Send the full findings to your inbox.
A specialist writes up every finding for Palo Verde Hematology Oncology, LTD with the methodology and public-source citations, in a form you can forward to your CFO or counsel. Tick the box if you also want a 15-minute walkthrough call.
We don't sell your email. By submitting, you agree that BenefitsLedger and its benefits advisory partner, WellthCare, may email or call you about these findings. Opt out anytime by replying. See our privacy policy.
Record built October 24, 2026 from U.S. Department of Labor, EBSA Form 5500 datasets (2025, 2024, 2023 plan years, 'Latest' files). Filings can run 7 to 10 months behind the plan year; always confirm against current plan documents. BenefitsLedger is not affiliated with the U.S. Department of Labor. Open the DOL filing search.